|
1
|
Ferra B, Holec-Gąsior L and Grąźlewska W:
Toxoplasma gondii recombinant antigens in the serodiagnosis
of toxoplasmosis in domestic and farm animals. Animals (Basel).
10(1245)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Galeh TM, Sarvi S, Montazeri M, Moosazadeh
M, Nakhaei M, Shariatzadeh SA and Daryani A: Global status of
Toxoplasma gondii seroprevalence in rodents: A systematic
review and meta-analysis. Front Vet Sci. 7(461)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Mordue DG, Monroy F, La-Regina M,
Dinarello CA and Sibley LD: Acute toxoplasmosis leads to lethal
overproduction of Th1 cytokines. J Immunol. 167:4574–4584.
2001.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gavrilescu LC and Denkers EY: IFN-gamma
overproduction and high level apoptosis are associated with high
but not low virulence Toxoplasma gondii infection. J
Immunol. 167:902–909. 2001.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hakimi MA, Olias P and Sibley LD:
Toxoplasma effectors targeting host signaling and transcription.
Clin Microbiol Rev. 30:615–645. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Helmby H, Takeda K, Akira S and Grencisa
RK: Interleukin (Il)-18 promotes the development of chronic
gastrointestinal helminth infection by downregulating IL-13. J Exp
Med. 194:355–364. 2001.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Abdalkareem EA, Ong CY, Lim BH and Khoo
BY: Neutralising FGF4 protein in conditioned medium of
IL-21-silenced HCT116 cells restores the invasiveness of the
colorectal cancer cells. Cytotechnology. 70:1363–1374.
2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Khan A and Grigg ME: Toxoplasma
gondii: Laboratory maintenance and growth. Curr Protoc
Microbiol. 44:20C.1.1–20C.1.17. 2017.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Eshtiyag A, Lim BH and Khoo BY: Silencing
of IL21 in HT29 and HCT116 cells to determine its role in the
proliferation of colorectal cancer associated with Schistosoma
mansoni infection. Australian J Basic Applied Sci. 9:39–44.
2015.
|
|
11
|
Eberl M, Beck E, Coulson PS, Okamura H,
Wilson RA and Mountford AP: IL-18 potentiates the adjuvant
properties of IL-12 in the induction of a strong Th1 type immune
response against a recombinant antigen. Vaccine. 18:2002–2008.
2000.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chang CY, Lee J, Kim EY, Park HJ, Kwon CH,
Joh JW and Kim SJ: Intratumoral delivery of IL-18 naked DNA induces
T-cell activation and Th1 response in a mouse hepatic cancer model.
BMC Cancer. 7(87)2007.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Srinivasan A, Salazar-Gonzalez RM, Jarcho
M, Sandau MM, Lefrancois L and McSorley SJ: Innate immune
activation of CD4 T cells in salmonella-infected mice is dependent
on IL-18. J Immunol. 178:6342–6349. 2007.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Spolski R and Leonard WJ: Interleukin-21:
Basic biology and implications for cancer and autoimmunity. Annu
Rev Immunol. 26:57–79. 2008.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ozaki K, Spolski R, Feng CG, Qi CF, Cheng
J, Sher A, Morse HC III, Liu C, Schwartzberg PL and Leonard WJ: A
critical role for IL-21 in regulating immunoglobulin production.
Science. 298:1630–1634. 2002.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Pot C, Jin H, Awasthi A, Liu SM, Lai CY,
Madan R, Sharpe AH, Karp CL, Miaw SC, Ho IC and Kuchroo VK: Cutting
edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21,
and the costimulatory receptor ICOS that coordinately act together
to promote differentiation of IL-10-producing Tr1 cells. J Immunol.
183:797–801. 2009.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Spolski R, Kim HP, Zhu W, Levy DE and
Leonard WJ: IL-21 mediates suppressive effects via its induction of
IL-10. J Immunol. 182:2859–2867. 2009.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Stumhofer JS, Silver JS and Hunter CA:
IL-21 is required for optimal antibody production and T cell
responses during chronic Toxoplasma gondii infection. PLoS
One. 8(e62889)2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Strengell M, Matikainen S, Sirén J,
Lehtonen A, Foster D, Julkunen I and Sareneva T: IL-21 in synergy
with IL-15 or IL-18 enhances IFN-gamma production in human NK and T
cells. J Immunol. 170:5464–5469. 2003.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Sareneva T, Matikainen S, Kurimoto M and
Julkunen I: Influenza A virus-induced IFN-alpha and IL-18
synergistically enhance IFN-gamma gene expression in human T cells.
J Immunol. 160:6032–6038. 1998.PubMed/NCBI
|
|
21
|
Nakanishi K, Yoshimoto T, Tsutsui H and
Okamura H: Interleukin-18 regulates both Th1 and Th2 responses. Ann
Rev Immunol. 19:423–474. 2001.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Pirhonen J, Sareneva T, Kurimoto M,
Julkunen I and Matikainen S: Virus infection activates IL-1 beta
and IL-18 production in human macrophages by a caspase-1-dependent
pathway. J Immunol. 162:7322–7329. 1999.PubMed/NCBI
|
|
23
|
Pien GC, Satoskar AR, Takeda K, Akira S
and Biron CA: Cutting edge: Selective IL-18 requirements for
induction of compartmental IFN-gamma responses during viral
infection. J Immunol. 165:4787–4791. 2000.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Abdalkareem EA, Tan GC, Abdalla HS, Lim BH
and Khoo BY: Identification of specific proteins in colorectal
cancer patients with Schistosoma mansoni infection as a
possible biomarker for the treatment of this infection. Asian Pac J
Trop Dis. 4 (Suppl):S720–S724. 2014.
|
|
25
|
Kuppala MB, Syed SB, Bandaru S, Varre S,
Akka J and Mundulru HP: Immunotherapeutic approach for better
management of cancer-role of IL-18. Asian Pac J Cancer Prev.
13:5353–5361. 2012.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Guo X, Zheng L, Jiang J, Zhao Y, Wang X,
Shen M, Zhu F, Tian R, Shi C, Xu M, et al: Blocking NF-κB is
essential for the immunotherapeutic effect of recombinant IL-18 in
pancreatic cancer. Clin Cancer Res. 22:5939–5950. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wigginton JM, Lee JK, Wiltrout TA, Alvord
WG, Hixon JA, Subleski J, Back TC and Wiltrout RH: Synergistic
engagement of an ineffective endogenous anti-tumor immune response
and induction of IFN-gamma and Fas-ligand-dependent tumor
eradication by combined administration of IL-18 and IL-2. J
Immunol. 169:4467–4474. 2002.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Stavropoulos NE, Ioachim E, Pappa L,
Hastazeris K and Agnantis NJ: Antiproliferative activity of
interferon gamma in superficial bladder cancer. Anticancer Res.
19:4529–4533. 1999.PubMed/NCBI
|
|
29
|
Chew LJ, King WC, Kennedy A and Gallo V:
Interferon-gamma inhibits cell cycle exit in differentiating
oligodendrocyte progenitor cells. Glia. 52:127–143. 2005.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Yasuda K, Nakanishi K and Tsutsui H:
Interleukin-18 in health and disease. Int J Mol Sci.
20(649)2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Gigley JP, Bhadra R and Khan IA: CD8 T
cells and Toxoplasma gondii: A new paradigm. J Parasitol
Res. 2011(243796)2011.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Jensen KDC, Camejo A, Melo MB, Cordeiro C,
Julien L, Grotenbreg GM, Frickel EM, Ploegh HL, Young L and Saeij
JP: Toxoplasma gondii superinfection and virulence during
secondary infection correlate with the exact ROP5/ROP18 allelic
combination. mBio. 6(e02280)2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Abdalkareem EA and Yin KB: A current
perspective of schistosomiasis in association with
colorectal carcinogenesis. Open Infect Dis J. 11:7–12. 2019.
|
